Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group has been recognized as an Outstanding Lean Management Enterprise in Cangzhou City for 2025.
Category:
TIME:2025-07-11

On July 8, the Cangzhou Municipal Bureau of Industry and Information Technology issued the “Notice on Announcing the Outstanding Lean Management Enterprises of Cangzhou for 2025.” Following procedures including enterprise applications, verification and recommendations by counties (cities and districts), tripartite evaluation, centralized deliberation, and public announcement, Hebei Guangxiang Pharmaceutical Co., Ltd. and 12 other enterprises were recognized as Outstanding Lean Management Enterprises of Cangzhou for 2025.
In recent years, Guangxiang Pharmaceutical Group has consistently regarded lean management as one of the core strategies for corporate development, striving to comprehensively enhance innovation capability, production efficiency, product quality, and operational management through technological innovation, process optimization, and digital empowerment. Adhering to the philosophy of “quality first, technology paramount, green and low-carbon practices, and the integration of digital and intelligent technologies,” Guangxiang Pharmaceutical is driven by innovation, continuously intensifying its R&D efforts, establishing national-level and multiple provincial-level high-caliber technology innovation platforms, overcoming a number of critical “bottleneck” challenges in core technologies, and steadily improving the quality and efficiency of bulk and specialty APIs. At the same time, the company integrates the concept of green development into its lean management approach, adopting clean production processes to reduce resource consumption, strengthening dynamic monitoring and management of pollutants, and thereby achieving a harmonious balance between economic benefits and ecological sustainability. By embedding lean management throughout the entire value chain—R&D, production, quality control, and operations—Guangxiang Pharmaceutical has, since the beginning of this year, secured EU CEP certification for its flagship product, caffeine, and obtained approval for seven new API products, including nicardipine hydrochloride, nimodipine, and felodipine, resulting in significant progress in corporate governance and business performance. According to the company’s leadership, the next step will be to build an even more efficient, flexible, and sustainable lean management system, accelerate technological innovation and digital transformation, continuously strengthen the company’s core competitiveness, and strive to make greater contributions to regional economic and social development.
Keywords:
Recommended News
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home